A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination
Akio Miyasaka,1,2 Yuichi Yoshida,1,2 Akiko Suzuki,1 Kei Sawara,1,3 Yasuhiro Takikawa1 1Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan; 2Department of Gastroenterology, Iwate Prefectural Ninohe Hospital, Ninohe, Iwate, Jap...
Guardado en:
Autores principales: | Miyasaka A, Yoshida Y, Suzuki A, Sawara K, Takikawa Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/faef1734927145a3979fb6afe189eef9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
por: María E. Cárdaba-García, et al.
Publicado: (2021) -
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
por: Ng KJ, et al.
Publicado: (2016) -
The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells
por: Andrew D. Huber, et al.
Publicado: (2018) -
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021) -
Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity
por: Wang,Wenting, et al.
Publicado: (2019)